Infliximab
- Part D specialty tier in 64% of formularies (2026Q3)
- Biologic
- REMICADE
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Infliximab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store unopened REMICADE ® vials in a refrigerator at 2°C to 8°C (36°F to 46°F).
- Freezing
- Not addressed
- Room temperature
- up to 4380 hours at or below 30°C (86°F)
Label statement
If needed, unopened REMICADE vials may be stored at room temperatures up to a maximum of 30°C (86°F) for a single period of up to 6 months but not exceeding the original expiration date.
- Back into the refrigerator
- Not allowed
Label statement
Once removed from the refrigerator, REMICADE cannot be returned to the refrigerator.
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (4)
- Store unopened REMICADE ® vials in a refrigerator at 2°C to 8°C (36°F to 46°F).
- If needed, unopened REMICADE vials may be stored at room temperatures up to a maximum of 30°C (86°F) for a single period of up to 6 months but not exceeding the original expiration date.
- The new expiration date must be written in the space provided on the carton.
- Once removed from the refrigerator, REMICADE cannot be returned to the refrigerator.
FDA label version 37, effective June 3, 2025. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Biosimilars
Remicade: 4 licensed biosimilar products, 0 interchangeable (FDA Purple Book). Compare presentations and dates
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.